Cellectis (CLLS) Total Debt (2014 - 2026)
Cellectis (CLLS) posted quarterly Total Debt of $76.4 million for Q1 2026, up 12.65% year-over-year from $67.8 million in Q1 2025, and down 9.55% quarter-over-quarter from $84.5 million in Q4 2025.
Cellectis (CLLS) Total Debt (2014 - 2026) Analysis & Trends
Cellectis' Total Debt history runs 13 years deep, the most recent figure standing at $76.4 million for Q1 2026.
- In Q1 2026, Total Debt rose 12.65% year-over-year to $76.4 million; the TTM figure through Mar 2026 stood at $76.4 million (up 12.65% YoY), while the FY2025 annual figure was $84.5 million, up 26.05% from the prior year.
- Total Debt for Q1 2026 stood at $76.4 million, down from $84.5 million in the prior quarter.
- The five-year high for Total Debt was $84.5 million in Q4 2025, with the low at $17.2 million in Q2 2022.
- The 5-year median for Total Debt is $63.5 million (2024), against an average of $54.2 million.
- The sharpest annual moves came in 2022 and 2024: Total Debt declined 26.69% in 2022, then surged 173.21% in 2024.
- Cellectis' Total Debt stood at $25.6 million in 2022, then soared by 112.4% to $54.4 million in 2023, then grew by 23.16% to $67.0 million in 2024, then advanced by 26.05% to $84.5 million in 2025, then decreased by 9.55% to $76.4 million in 2026.
- Business Quant data shows CLLS's Total Debt at $76.4 million in Q1 2026, $84.5 million in Q4 2025, and $81.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | 76.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.40 Mn |
| Dec 31, 2025 | 84.47 Mn |
| Sep 30, 2025 | 81.64 Mn |
| Jun 30, 2025 | 74.09 Mn |
| Mar 31, 2025 | 67.82 Mn |
| Dec 31, 2024 | 67.02 Mn |
| Sep 30, 2024 | 66.93 Mn |
| Jun 30, 2024 | 63.47 Mn |
| Mar 31, 2024 | 67.79 Mn |
| Dec 31, 2023 | 54.41 Mn |
| Sep 30, 2023 | 48.31 Mn |
| Jun 30, 2023 | 45.46 Mn |
| Mar 31, 2023 | 24.81 Mn |
| Dec 31, 2022 | 25.62 Mn |
| Sep 30, 2022 | 25.08 Mn |
| Jun 30, 2022 | 17.21 Mn |
| Mar 31, 2022 | 30.95 Mn |
| Dec 31, 2021 | 22.38 Mn |
| Sep 30, 2021 | 22.77 Mn |
| Jun 30, 2021 | 23.48 Mn |